Heli-FX EndoAnchor System
Device Aortic EndoAnchors
PDI 00763000225964
General payments
$492,494
Research payments
$571,085
Through program year 2025, $492,494 in general payments and $571,085 in research payments were reported against Heli-FX EndoAnchor System (Aortic EndoAnchors).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $132,625 | 860 |
| 2025 | Research | $16,755 | 4 |
| 2024 | General | $147,717 | 718 |
| 2024 | Research | $75,837 | 31 |
| 2023 | General | $151,027 | 581 |
| 2023 | Research | $42,909 | 32 |
| 2022 | General | $40,120 | 249 |
| 2022 | Research | $181,507 | 62 |
| 2021 | General | $21,005 | 144 |
| 2021 | Research | $254,078 | 69 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 28 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 40 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
2,552 general · 198 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.